Johnson & Johnson +1.6%

Why it matters

Johnson & Johnson's rise could reflect defensive buying in healthcare amid market volatility, or positive developments in its pipeline.

Details

Johnson & Johnson (JNJ) moved +1.6% in the latest period (1d). Close: 270.20, prior: 265.85.

Related assets & topics

Sources

• yfinance · finance.yahoo.com · 2026-09-01 00:00 UTC

Related stories

• RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) plus LAZCLUZE® (lazertinib) with prophylactic strategies shows low rates of treatment-related events at WCLC 2026
  News · 2026-09-15 03:00 UTC
• Johnson & Johnson -1.9%
  Price move · 2026-09-15 00:00 UTC
• Johnson & Johnson shares rise on Apollo Global takeover talks - Investing.com
  News · 2026-09-14 11:37 UTC
• Johnson & Johnson +1.6%
  Price move · 2026-09-14 00:00 UTC
• JNJ filed 8-K on 2026-09-14
  SEC Filing · 2026-09-14 00:00 UTC

More on the feed →